• A case of monozygotic twins with hereditary spastic paraplegia type 4 and epilepsy, of whom only one developed narcolepsy type 1
• A qualitative exploration of the lived experience of mothers caring for a child with narcolepsy
• A Rare Presentation of Narcolepsy With Cataplexy After Vaccines in a Genetically Susceptible Elderly Woman: A Case Report
• A series of 7 cases of patients with narcolepsy with hypocretin deficiency without HLA DQB1*06:02 allele
• A unique association? A narcolepsy type 1 case comorbid with Primary Biliary Cholangitis
• A vertebrate family without a functional Hypocretin/Orexin arousal system
• Ageing-related modification of sleep and breathing in orexin-knockout narcoleptic mice
• Alcohol perturbed locomotor behavior, metabolism, and pharmacokinetics of gamma-hydroxybutyric acid in rats
• Amygdala neurocircuitry at the interface between emotional regulation and narcolepsy with cataplexy
• Association between human leukocyte antigen class II-DR-DQ and narcolepsy: a case control study
• Atypical isolated cataplexy: two case reports and a mini-review
• Awakening Change-Embracing Disability in Medical Training
• Bi-allelic variants in HCRT cause autosomal recessive narcolepsy
• Cataplexy
• Cataplexy Mistaken for Seizures in a Patient With Undiagnosed Narcolepsy Type I
• Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial
• Cell-based versus enzyme-linked immunosorbent assay for detection of anti-Tribbles homolog 2 autoantibodies in Chinese patients with narcolepsy
• Challenges in the Management of Narcolepsy in a Resource Limited Setting: A Case Report
• Characteristics of hypersomnia due to inflammatory demyelinating diseases of the central nervous system
• Child Neurology: Common Occurrence of Narcolepsy Type 1 and Myasthenia Gravis
• Clinical Evaluation and Management of Narcolepsy in Children and Adolescents
• Connecting the dots: An updated review of the role of autoimmunity in narcolepsy and emerging immunotherapeutic approaches
• Constructing a cataplexy face prediction model for narcolepsy type 1 based on ResNet-18
• Correlation analysis between HLA-DQA1*0102/DQB1*0602 genotypes and narcolepsy patients in China
• Deficiency of orexin signaling during sleep is involved in abnormal REM sleep architecture in narcolepsy
• Dopamine release in the nucleus accumbens promotes REM sleep and cataplexy
• Drop attacks: a practical guide
• Effect of Repeated Administration of ɣ-Valerolactone (GVL) and GHB in the Mouse: Neuroadaptive Changes of the GHB and GABAergic System
• Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy
• Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the SEGUE study
• Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study
• Effectiveness of an intervention program on physical activity in children with narcolepsy type 1
• Eurycoma longifolia (Tongkat Ali) supplementation enhances sleep and wake consolidation in wild-type, but not in narcoleptic mice
• Eyelid Closure Behavior of Patients with Idiopathic and Nonorganic Hypersomnia, Narcolepsy-Cataplexy, and Healthy Controls in the Maintenance of Wakefulness Test
• Headache improves with armodafinil
• Hemiplegic Migraines Exacerbated using an Injectable GLP-1 Agonist for Weight Loss
• Hits and misses with animal models of narcolepsy and the implications for drug discovery
• Identification of bidirectional causal links between gut microbiota and narcolepsy type 1 using Mendelian randomization
• Idiopathic hypersomnia and Kleine-Levin syndrome
• Idiopathic hypersomnia with a video recording of a spontaneous sleep attack: A case report
• Immune Reconstitution Inflammatory Syndrome Due to HIV Treatment as a Potential Trigger: A Case Report with Late-Onset Narcolepsy
• Impact of Taiwan's 2021 COVID-19 lockdown on the symptom severity and quality of life of patients with narcolepsy
• Impaired Cognition in Narcolepsy: clinical and neurobiological perspectives
• Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary
• Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary
• Infection, vaccination and narcolepsy type 1: Evidence and potential molecular mechanisms
• International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology
• LC-MS/MS Quantitation of HILIC-Enriched <em>N</em>-glycopeptides Derived from Low-Abundance Serum Glycoproteins in Patients with Narcolepsy Type 1
• Long-term follow-up of symptom and quality of life changes in patients with narcolepsy during and after the COVID-19 pandemic
• Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate
• Making sense of narcolepsy: A qualitative exploration of how persons with narcolepsy perceive symptoms and their illness experience
• Multidrug resistant narcolepsy
• Narcolepsies, update in 2023
• Narcolepsy and pediatric acute-onset neuropsychiatric syndrome: A case report that suggests a putative link between the two disorders
• Narcolepsy and rapid eye movement sleep
• Narcolepsy following COVID-19: A case report and review of potential mechanisms
• Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2
• Narcolepsy type 1 and Sydenham chorea - Report of 3 cases and review of the literature
• Narcolepsy: an interface among neurology, immunology, sleep, and genetics
• Navigating narcolepsy: exploring coping strategies and their association with quality of life in patients with narcolepsy type 1
• Neural Control of REM Sleep and Motor Atonia: Current Perspectives
• Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary
• Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
• Pharmacological options for narcolepsy: are they the way forward?
• Phenomenology and psychiatric correlates of pseudocataplexy
• Pitolisant: Pediatric First Approval
• Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations
• Prader-Willi syndrome: an update
• Prevalence and incidence of narcolepsy symptoms in the US general population
• Quality of life in adolescents with narcolepsy type 1- a transversal study in a tertiary hospital
• REM sleep breathing: Insights beyond conventional respiratory metrics
• Research Progress in the Correlation Between Dopamine and Clinical Characterization of Narcolepsy
• Role of Daytime Continuous Polysomnography in the Diagnosis of Pediatric Narcolepsy Type 1
• Serum <em>N</em>-Glycan Profiling of Patients with Narcolepsy Type 1 Using LC-MS/MS
• Serum metabolomics study of narcolepsy type 1 based on ultra-performance liquid chromatography-tandem mass spectrometry
• Sex disparities in clinical features and burden of narcolepsy type 1
• Single cell transcriptomics of cerebrospinal fluid cells from patients with recent-onset narcolepsy
• Sleep Disorders in Childhood
• Sleep paralysis during naptime as initial symptom of narcolepsy
• Sleep Stage Transitions and Sleep-Dependent Memory Consolidation in Children with Narcolepsy-Cataplexy
• Sleep-related motor disorders
• Status Cataplecticus Induced by an Abrupt Duloxetine Withdrawal-A Case Report
• Striatal dopamine regulates sleep states and narcolepsy-cataplexy
• Tetrad of Narcolepsy Type 1: Treatment and Management
• The Burden of Narcolepsy in Adults: A Population Sampling Study Using Personal Media
• The present and future of synthetic orexin receptor agonists
• The role of orexinergic system in the regulation of cataplexy
• The therapeutic potential of opioids in narcolepsy type 1: A systematic literature review and questionnaire study
• Theory of Mind impairment in childhood narcolepsy type 1: a case-control study
• Type 1 Narcolepsy in Pregnancy: A Case Report and Review of Literature
• Vagus nerve stimulation for the treatment of narcolepsy
• Validation of the Brazilian Portuguese version of the Stanford cataplexy questionnaire
• Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) Trial
• What is Cataplexy?